Business, energy, technology, markets and global industry news from Business News Today

medical devices

PharmaDeviceNews medical devices
Eli Lilly and Company has committed $3.5 billion toward a new Pennsylvania facility dedicated to manufacturing next-generation injectable medicines, including retatrutide.
Pharma & Biotech

Lilly’s $3.5bn Pennsylvania site will anchor U.S. manufacturing for next-gen injectables including retatrutide

Eli Lilly and Company has announced a $3.5 billion investment to build a new injectable medicine and device manufacturing facility in Lehigh Valley, Pennsylvania. The site will focus on producing next-generation weight-loss medicines, including the investigational triple hormone receptor agonist retatrutide. Set to become operational by 2031, this is Lilly’s fourth new U.S. manufacturing site

Read More
Medical Devices & Diagnostics

Why UVDI’s new V-MIX air disinfection system could reshape HVAC pathogen control

Find out how UVDI’s V-MIX UV-C disinfection system is pushing upper-room air safety beyond hospitals into schools, offices, and airports.

Read More
Abanza secures 510(k) for QuadLock ACL system with 500% reduction in displacement
Medical Devices & Diagnostics

Abanza gains 510(k) for QuadLock ACL system: But is this a clinical leap or an engineering refinement?

Abanza Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for QuadLock, its novel knotless fixation system for anterior cruciate ligament (ACL) reconstruction. The system, which features a bidirectional tension-adjustable design, reportedly offers over a 500% reduction in cyclic displacement compared to conventional fixation methods such as cortical buttons and interference screws, targeting

Read More
Medical Devices & Diagnostics

Is Myriad setting a new performance and pricing benchmark in bioscaffold trauma use?

Can Aroa’s bioscaffold platform reshape trauma care economics? See what Myriad’s MASTRR data means for hospitals, surgeons, and reimbursement.

Read More
Medical Devices & Diagnostics

FDA clears BEAR Implant label for lower osteoarthritis risk: What this changes in ACL surgery

FDA clears PTOA risk reduction claim for Miach Orthopaedics’ BEAR Implant. Find out what this means for ACL treatment, patients, and future adoption.

Read More
Representative image of GammaTile being implanted during brain tumor surgery, illustrating the intraoperative radiation approach tested in the BRIDGES trial for newly diagnosed glioblastoma.
Medical Devices & Diagnostics

GT Medical Technologies’ BRIDGES trial begins enrollment, testing GammaTile in newly diagnosed glioblastoma patients

GT Medical Technologies has announced the first patient enrollments in its BRIDGES trial, a randomized clinical study assessing the use of GammaTile therapy in newly diagnosed glioblastoma. The trial introduces GammaTile at the time of initial tumor resection, marking a notable shift from the conventional glioblastoma radiation timeline, which typically delays radiation until several weeks

Read More
iotaMotion receives FDA clearance for pediatric use of iotaSOFT system
Medical Devices & Diagnostics

Robotic cochlear implants approved for kids: Is iotaSOFT reshaping pediatric ENT standards?

iotaMotion, Inc. has received U.S. Food and Drug Administration 510(k) clearance to expand the approved use of its iotaSOFT Robotic-Assisted Cochlear Implant Insertion System for children as young as four years old. This regulatory milestone makes the iotaSOFT system the first robotic-assisted cochlear insertion platform authorized for use in school-aged pediatric patients, expanding access to

Read More
Medical Devices & Diagnostics

CornerLoc TransLoc 3D System hits key milestones in SPARTAN trial

CornerLoc has disclosed 6-month interim results from the ongoing SPARTAN Study evaluating its TransLoc 3D System, a lateral-oblique sacroiliac (SI) joint fusion platform. The data, published in the Pain Physician Journal, reported significant improvements in pain and function among enrolled patients, with no device-related or procedure-related adverse events during the evaluation period. The prospective multicenter

Read More
Medical Devices & Diagnostics

Can Avatar Medical’s glasses-free 3D imaging shift patient communication from confusion to clarity?

Avatar Medical is set to introduce Eonis Vision, a glasses-free 3D medical imaging system, at CES 2026. The product, developed in collaboration with Belgian display specialist Barco and powered by high-performance Dell hardware, is aimed at enhancing the clarity of doctor–patient communication. While the original Avatar Medical Vision software is already FDA-cleared, the updated version

Read More
XRlabs partners with NVIDIA to bring real-time AI perception to surgical scopes
Medical Devices & Diagnostics

XRlabs taps NVIDIA’s Jetson Thor and Isaac platform to rewire real-time intelligence in surgical scopes

XRlabs has disclosed it is integrating NVIDIA Jetson Thor and NVIDIA Isaac for Healthcare to develop an AI-powered retrofit system for surgical visualisation tools, aiming to deliver real-time perception, tool tracking, and intent-aware automation for neurosurgery and other minimally invasive procedures. The system is currently under early-stage clinical evaluation. Unlike traditional surgical robotics or integrated

Read More